Florida Pulmonary Research Institute, LLC

Winter Park, Florida 32789

0 studies enrolling now · 19 studies all time

What they study most

Asthma, Atopic Dermatitis, COPD, COVID-19, Cataplexy, Chronic Cough, Chronic Obstructive Pulmonary Disease, Excessive Daytime Sleepiness, Herpes Zoster, Idiopathic Hypersomnia, Idiopathic Pulmonary Fibrosis, Lung Cancer (Diagnosis)

Studies at this site

• A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age — Stopped early
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed
• A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma — Completed
• A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough — Completed
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
• A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19 — Stopped early
• A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD — Completed
• A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia — Completed
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller — Completed
• A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients — Completed
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis — Completed
• Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy — Completed
• Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer — Completed
• Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD — Completed
• Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP) — Completed
• An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma — Stopped early
• Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD — Completed